What to know: The FDAs Pharmacy Compounding Advisory Committee (PCAC) voted last week to recommend adding six popular peptides, including BPC-157, to the 503A bulk drug list, a decision that could expand access for American consumers if the FDA formally adopts the recommendation
Most scientific results come from the study of its effects in rodents
doi:10.1371/journal.pone.0033944 Lederman RJ, Mendelsohn FO, Anderson RD, Saucedo JF, Tenaglia AN, Hermiller JB, Hillegass WB, Rocha-Singh K, Moon TE, Whitehouse MJ et al (2002) Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial
Discontinuing or reducing HCG often resolves early symptoms
Call Anita Petruzzelli, M.D